# Histotripsy for Ablation of Liver Tumours in Asia

> **NCT07428356** · NA · RECRUITING · sponsor: **National Cancer Centre, Singapore** · enrollment: 40 (estimated)

## Conditions studied

- Liver Malignant Tumors

## Interventions

- **DEVICE:** Histotripsy using HistoSonics Edison™ System

## Key facts

- **NCT ID:** NCT07428356
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-07
- **Primary completion:** 2027-11-07
- **Final completion:** 2029-05-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07428356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07428356, "Histotripsy for Ablation of Liver Tumours in Asia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07428356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*